John Virapen

from Wikipedia, the free encyclopedia

John Virapen (born 1943 as a child of Indian immigrants in British Guiana ; † April 26, 2015 ) was the manager of the pharmaceutical companies Eli Lilly and Company (1980 to 1988 managing director) and Novo Nordisk , who wrote a story in German in 2006 under the pseudonym John Rengen Manipulated drug approval. The novel Rubio spits it out. A story from a Pharma-Insider shows parallels between the main character and the author. In his book, the author describes manipulations in the approval of the antidepressant Prozac in Sweden , during which he bribed professors, experts and state officials. In December 2006 Virapen appeared in Hamburg at an event organized by the Scientology Members-founded Commission for Violations of Human Rights in Psychiatry . Virapen told the taz that they only used the forum and beyond that they had no connections to the KVPM eV or Scientology .

In 2008, a non-fiction book followed under his real name, which was translated from the German original into 18 other languages ​​and discussed controversially, with many enthusiastic comments from pharmacritical patients in online forums, who saw their skepticism towards the pharmaceutical industry confirmed. In addition to numerous other insiders among other medical and pharmaceutical industries joined Virapen in the same year in the Frontal21 - Documentation " The pharmaceutical cartel " in which, in addition Prozac and preparations same type of action will be discussed. Virapen gave insights into their motives .

Works

  • John Rengen, Olaf Nollmeyer: Rubio spits it out . A story from a pharma insider. Trafo, Berlin 2006, ISBN 978-3-89626-605-7 .
  • John Virapen: Side Effect Death . An ex-manager of the pharmaceutical industry unpacks; [the truth about bogus science, corruption, bribery, manipulation and fraud in the pharmaceutical world]. Bucher, Kleinsendelbach 2009 (5th, revised and updated edition), ISBN 978-3-934246-04-1 (German first edition: side effect death. Corruption in the pharmaceutical industry . Neuer Europa-Verlag, Leipzig 2008, ISBN 978-3 -86695-920-0 ).
  • John Virapen: Side Effects Death - Confessions of a Pharma-Insider . Mazaruni Publishing, March 2009 (1st e-book, English)

Web links

Individual evidence

  1. John Virapen - en insider från läkemedelsjätten Eli Lilly har gått vidare , accessed on July 5, 2018
  2. Markus Grill: A Story from a Pharma-Insider ( Memento from September 3, 2006 in the Internet Archive ) August 18, 2006
  3. Bribes, whore houses, manipulated studies ( memento from April 26, 2009 in the Internet Archive ) KVPM press release of December 8, 2006
  4. Elke Brüser: A billion dollar business for the pharmaceutical company Eli Lilly , Die Tageszeitung, January 12, 2007
  5. Discussion in the pharmamkting blogspot